Vera Therapeutics Inc (NASDAQ:VERA) price closed higher on current market day and jumping 1.94% above its previous close.
A look at the daily price movement shows that the last close reads $22.19. Taking into account the 52-week price action we note that the stock hit a 52-week high of $51.61 and 52-week low of $18.53. The stock added 4.19% on its value in the past month.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 5 analysts have assigned VERA a recommendation rating as follows: 1 rate it as a Hold; 3 advise Buy while 1 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Vera Therapeutics Inc (VERA) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that VERA’s price is at present -0.97% off the SMA20 and 0.18% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 47.78, with weekly volatility standing at 14.43%. The indicator jumps to 14.00% when calculated based on the past 30 days. Vera Therapeutics Inc (NASDAQ:VERA)’s beta value is holding at 1.14, while the average true range (ATR) indicator is currently reading 2.56. Considering analysts have assigned the stock a price target range of $65-$65 as the low and high respectively, we find the trailing 12-month average consensus price target to be $65. Based on this estimate, we see that current price is roughly -187.36% off the estimated low and -187.36% off the forecast high. Investors will no doubt be excited to see the share price fall to $65, which is the median consensus price, and at that level VERA would be -187.36% from current price.
Current records show that the company has 63.77M in outstanding shares. The insiders’ percentage holdings are 24.63% of outstanding shares while the percentage share held by institutions stands at 90.09%. But the -46.51% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
